Philadelphia Trust CO Alkermes Plc. Transaction History
Philadelphia Trust CO
- $1.36 Billion
- Q4 2024
A detailed history of Philadelphia Trust CO transactions in Alkermes Plc. stock. As of the latest transaction made, Philadelphia Trust CO holds 100,000 shares of ALKS stock, worth $3.32 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$3.32 Million% of portfolio
0.21%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$967 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$614 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$407 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$293 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$251 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.45B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...